Clinical trial
Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function
NCT04530383
Study timeline
Study start (actual)2022-02-14Date precision: day
Registry last updated2026-04-15
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Cystic Fibrosis-related Diabetesunresolved
Cystic Fibrosisunresolved
Interventions
Metformin HydrochlorideDRUG · verified · RxNorm: metformin hydrochloride
Sponsors & collaborators
University of Kansas Medical Centerlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04530383 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.